Pregnancy

Flo Health’s App Wins Google Play “Best of 2025” Award for Best for Watches in Hong Kong, Taiwan, and Macau

LONDON, Jan. 9, 2026 /PRNewswire/ -- Flo Health, the company behind the globally trusted Flo App and the #1 women's…

4 weeks ago

Aqua Sculpt Reviews: Breakthrough Hydro-Nutrient Complex Targets Deep Tissue Hydration and Metabolic Sculpting

ST. PETERSBURG, FL / ACCESS Newswire / January 8, 2026 / SummaryAqua Sculpt has emerged as a significant topic of…

4 weeks ago

Best Tummy Tuck in Las Vegas

The Best Tummy Tuck in Las Vegas Is by Dr. Ahmed. LAS VEGAS, NV / ACCESS Newswire / January 5,…

4 weeks ago

Best Chocolate Weight Loss Supplement: Consumer Analysis Examines Cacao GLP-1 Research as January Wellness Interest Surges

Consumer analysis evaluates Earth Echo Cacao Bliss ingredient disclosures, ceremonial-grade processing claims, and published GLP-1 research frequently referenced in chocolate-based…

1 month ago

Best ACV Gummies 2026 Report: True Keto Fusion Analyzed in New Year Keto-ACV Industry Analysis

An Informational Buyer's Guide to Apple Cider Vinegar Gummies, BHB Ketogenic Support Ingredients, Weight Wellness Formulations, and What Label Transparency…

1 month ago

OTO Fertility Launches World’s First AI-Powered Platform & Wearable for Predictive Reproductive Insight

A new frontier in fertility innovation begins as OTO introduces its advanced platform, delivering personalized reproductive insights to users across…

1 month ago

Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering

CHATHAM, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated…

1 month ago

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect…

1 month ago

Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)

CELEBRATION, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company…

1 month ago